FDA de­vel­ops pi­lot to har­mo­nize in­ter­na­tion­al gene ther­a­py reg­u­la­tions

The FDA is set­ting out to stream­line in­ter­na­tion­al reg­u­la­tions of gene ther­a­pies with a pi­lot pro­gram to re­view ap­pli­ca­tions along­side glob­al reg­u­la­to­ry part­ners, an agency spokesper­son told End­points News.

The spokesper­son said that the pro­gram, called the Col­lab­o­ra­tion on Gene Ther­a­pies Glob­al Pi­lot, is part of the agency’s work to­ward glob­al reg­u­la­to­ry har­mo­niza­tion of these prod­ucts. The FDA is work­ing with in­ter­na­tion­al part­ners, glob­al reg­u­la­tors and the World Health Or­ga­ni­za­tion on these ef­forts, they said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER